logo

Catalyst Pharmaceutical Partners Inc. (CPRX)



Trade CPRX now with
  Date
  Headline
1/4/2019 8:05:11 AM Catalyst Announces Publication Of Clinical Data From The Investigator-Sponsored Phase IIb Study Evaluating Firdapse
12/18/2018 12:05:24 PM Catalyst Pharmaceuticals Announces Definitive Agreement With Endo For Vigabatrin Tablets
12/3/2018 8:10:06 AM Catalyst Expects Firdapse U.S. Launch Scheduled For Early In Q1 Of 2019
8/20/2018 8:04:11 AM Catalyst Pharma Appoints Stanley Iyadurai As VP Of Clinical Development
6/13/2018 8:03:28 AM Catalyst Pharmaceuticals Appoints Daniel Brennan As Chief Commercial Officer
5/29/2018 8:05:39 AM Catalyst : FDA Accepts NDA And Priority Review Status For Firdapse For Lambert-Eaton Myasthenic Syndrome
4/19/2018 8:03:42 AM Catalyst Announces Enrollment Of First Patient In Phase 3 Trial Of Firdapse In MuSK Antibody Positive Myasthenia Gravis
3/29/2018 8:20:33 AM Catalyst Announces Submission Of NDA For Firdapse For Treatment Of Lambert-Eaton Myasthenic Syndrome